Purpose Acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) primarily afflict older individuals. (95% CI, 24% to 49%), respectively, for patients with AML (= .06); and 42% (95% CI, 35% to 49%), 35% (95% CI, 27% to 43%), 45% (95% CI, 36% to 54%), and 38% (95% CI, 25% to DLL1 51%), respectively, for patients… Continue reading Purpose Acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) primarily afflict